Medtronic cardiovascular unit shows Q1 growth

Medical device manufacturer Medtronic’s cardiovascular business unit reported a positive uptick in revenues for its fiscal 2008 first quarter (end-July 27, 2007) compared with the same quarter last year.

The business segment stated revenues of $486 million for the period, an 8 percent increase compared with the same period the prior fiscal year. The Minneapolis-based firm said that the unit’s sales growth was driven by coronary stents and endovascular products.

Medtronic said that its coronary stent revenue of $152 million for the quarter grew 27 percent and its endovascular revenue grew 13 percent.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup